Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy
- 4 March 2008
- journal article
- Published by Elsevier in Biomaterials
- Vol. 29 (12), 1920-1930
- https://doi.org/10.1016/j.biomaterials.2007.12.038
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effect of Intratumoral Injection on the Biodistribution, the Therapeutic Potential of HPMA Copolymer-Based Drug Delivery SystemsNeoplasia, 2006
- Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene deliveryJournal of Controlled Release, 2005
- Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in miceJournal of Biomedical Optics, 2005
- In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor XenograftsCancer Research, 2004
- Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic AcidLangmuir, 2003
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosisNature, 1990
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971